Net profit of Shukra Pharmaceuticals rose 544.30% to Rs 20.36 crore in the quarter ended December 2025 as against Rs 3.16 crore during the previous quarter ended December 2024. Sales rose 269.85% to Rs 39.13 crore in the quarter ended December 2025 as against Rs 10.58 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended | ||
| Dec. 2025 | Dec. 2024 | % Var. | |
| Sales | 39.13 | 10.58 | 270 |
| OPM % | 69.31 | 37.15 | - |
| PBDT | 27.66 | 4.79 | 477 |
| PBT | 26.82 | 4.09 | 556 |
| NP | 20.36 | 3.16 | 544 |
Powered by Capital Market - Live News